Venture capital in ’23 for healthtech with Chris Moniz from HSBC Innovation Banking on Diagnosing Healthtech

Industry headlines are constantly buzzing with M&A activity and Healthtech VC investment trends.

On this episode of Diagnosing Healthtech, Jeff Englander (Healthcare Strategist) and Redox’s Sarah Bottjen (Director of Sales Enablement) delve into these topics in an interview with HSBC Innovation Banking’s Chris Moniz. 

In addition to his role as Managing Director, Chris is a contributing author to HSBC Innovation Banking’s 1H 2023 Venture Healthcare Report, which combines analytics and expertise to provide industry perspectives and actionable insight to companies and investors. 

Related Posts

Podcasts

Rethinking chronic pain management with Jennie Shulkin on Diagnosing Healthtech

https://www.youtube.com/watch?v=mimCIJFgN48 According to the U.S. Pain Foundation, more than 50 million Americans live with chronic pain, yet traditional…

By Abbey Cox – April 18, 2024

Podcasts

Challenges and opportunities in expanding access and equity in clinical trials with Tony Clapsis on Diagnosing Healthtech

https://www.youtube.com/watch?v=btqvFGC384s Clinical trials are notoriously inefficient. Almost 90% of trials fail to reach their recruitment goals and with dropout rates…

By Abbey Cox – April 8, 2024

Podcasts

Healthcare cybersecurity post-hack with Scott Giordano on Diagnosing Healthtech

https://www.youtube.com/watch?v=HMWADxNZDic&t=2s The implications of the recent healthcare hack continue to reverberate through the ecosystem. Many are wondering with…

By Abbey Cox – April 1, 2024